follow-up period of 1 year. The infection rate in this study was 2.4%, greater than described in other recent series (1,5-9). All infections required hospitalization and were treated with parenteral antibiotics and complete system removal. Infection rates differed significantly according to whether patients had a CSH or not; infection rates were 11% in patients with CSH, versus 1.5% in those without. The only factor found in multivariate analysis to be associated with development of an infection was CSH (hazard ratio: 7.7; 95% confidence interval: 2.9 to 20.5; p < 0.0001).
include strict definitions of both clinically significant hematoma (CSH) and significant infections, and the follow-up period of 1 year. The infection rate in this study was 2.4%, greater than described in other recent series (1,5-9). All infections required hospitalization and were treated with parenteral antibiotics and complete system removal. Infection rates differed significantly according to whether patients had a CSH or not; infection rates were 11% in patients with CSH, versus 1.5% in those without. The only factor found in multivariate analysis to be associated with development of an infection was CSH (hazard ratio: 7.7; 95% confidence interval: 2.9 to 20.5; p < 0.0001).
Nevertheless, 89% of patients with a CSH did not develop infection requiring hospitalization or device removal, and more than one-half of patients who un- 
